P-107 LEAP-012: A randomized, double-blind, phase 3 study of pembrolizumab plus lenvatinib in combination with transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma not amenable to curative treatment
| Publication | Article in Annals of Oncology, published July 2020 |
|---|---|
| Authors | S. Ogasawara, J. Llovet, A. El-Khoueiry, A. Vogel, D. Madoff, R. Finn, Z. Ren, K. Modi, J. Li, A....[ show more ] |
This is the public page for a publication record in Dimensions, a free research insights platform that brings together information about funding, scholarly outputs, policy, patents and grants.
Loading metrics…